Panc1 (krasgat) Uses, Dosage, Side Effects and more
Panc1 (krasgat) is under investigation in clinical trial NCT01676259 (A Phase 2 Study of Sig12d LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer).
| Trade Name | Panc1 (krasgat) |
| Generic | siG12D LODER |
| siG12D LODER Other Names | Panc1 (krasgat), SiG12D LODER |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
